Future applications and innovations of clinical breast magnetic resonance imaging

Topics in Magnetic Resonance Imaging

Volumn 19, Issue 3, 2008, Pages 171-176

  Partridge, Savannah C ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Breast; Diffusion weighted imaging (DWI); High field MRI; Innovations; Magnetic resonance imaging (MRI); Magnetic resonance spectroscopy (MRS)

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; FORECASTING; MASS SCREENING; PATHOLOGY; REVIEW;

BREAST; BREAST NEOPLASMS; FEMALE; FORECASTING; HUMANS; MASS SCREENING;

EID: 58149153168     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e31818a4090     Document Type: Article

References (39)

1. Kuhl CK, Jost P, Morakkabati N, et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology. 2006;239:666-676.
2. Kuhl CK, Kooijman H, Gieseke J, et al. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. Radiology. 2007;244:929-930.
3. Wiesinger F, Van de Moortele G, Adriany PF, et al. Potential and feasibility of parallel MRI at high field. NMR Biomed. 2006;19:368-378.
4. Ladd ME. High-field-strength magnetic resonance: potential and limits. Top Magn Reson Imaging. 2007;18:139-152.
5. Wiesinger F, Boesiger P, Pruessmann KP. Electrodynamics and ultimate SNR in parallel MR imaging. Magn Reson Med. 2004;52:376-390.
6. Park MJ, Cha ES, Kang BJ, et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol. 2007;8:390-396.
7. Kuroki-Suzuki S, Kuroki Y, Nasu K, et al. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci. 2007;6:21-27.
8. Yoshikawa MI, Ohsumi S, Sugata S, et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med. 2007;25:218-223.
9. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005;4:35-42.
10. Sinha S, Lucas-Quesada FA, Sinha U, et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002;15:693-704.
11. Rubesova E, Grell AS, De Maertelaer V, et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging. 2006;24:319-324.
12. Marini C, Iacconi C, Giannelli M, et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007;17:2646-2655.
13. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-178.
14. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci. 2008;7:23-29.
15. Chenevert T, Meyer C, Moffat B, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging. 2002; 1:336-343.
16. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia. 2004;6:831-837.
17. Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843-847.
18. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000;92:2029-2036.
19. Sharma U, Danishad KK, Seenu V, et al. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally-advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed. 2008 (epub ahead of print).
20. Bammer R, Keeling SL, Augustin M, et al. Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med. 2001;46:548-554.
21. Kuhl CK, Gieseke J, Von Falkenhausen M, et al. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. Radiology. 2005;234:517-526.
22. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology. 2001;220:40-46.
23. Roebuck JR, Cecil KM, Schnall MD, et al. Human breast lesions: characterization with proton MR spectroscopy. Radiology. 1998; 209:269-275.
24. 1H MR spectroscopy. J Magn Reson Imaging. 1999;10:159-164.
25. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer. 2001;84:1016-1022.
26. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging. 1998;8:1191-1197.
27. Cecil KM, Schnall MD, Siegelman ES, et al. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat. 2001;68:45-54.
28. Bolan PJ, Nelson MT, Yee D, et al. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res. 2005;7:149-152.
29. Haddadin IS, McIntosh A, Meisamy S, et al. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed. 2007 Oct 24 (epub ahead of print).
30. 1H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging. 2008;26(4):523-531.
31. Meisamy S, Bolan PJ, Baker EH, et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology. 2005;236:465-475.
32. Huang W, Fisher PR, Dulaimy K, et al. TM detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology. 2004;232:585-591.
33. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology. 2006;239:686-692.
34. Bartella L, Thakur SB, Morris EA, et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology. 2007;245:80-87.
35. 1H MR spectroscopy - a pilot study at 4 T. Radiology. 2004;233:424-431.
36. Jacobs MA, Barker PB, Argani P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging. 2005;21:23-28.
37. 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time. Magn Reson Imaging. 2008;26:360-366.
38. 1H MRS of breast lesions. Magn Reson Med. 2002;48:215-222.
39. Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005;184: 1774-1781.